Precise Bio is a pioneering biotechnology startup with a strong focus on bio-fabricated tissues and organs. Founded in 2015 and based in the United States, the company's mission revolves around developing and commercializing 4D bio-fabricated functional tissues and organs aimed at saving lives and enhancing life quality. By leveraging a combination of world-class tissue engineering and transplantation expertise with best-in-class bio-printing, Precise Bio has created a scalable bio-fabrication platform that addresses current industry challenges and aims to make complex human organs available for transplantation. Notably, their recent $12.00M Venture Round investment received on 18 July 2022 has attracted the attention of established investors such as K20 Fund and Carl Zeiss Meditec.
Precise Bio
Bio-fabricated tissues and organs
Winston-salem, United States
36 employees
Venture round
Total: $27.53M
Biotechnology, Health Care
General Information
Winston-salem, United States
BounceWatch is an independent company data service, not affiliated with Precise Bio. To contact Precise Bio, visit precise-bio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Precise Bio compare?
A PDF of Precise Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Precise Bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Precise Bio
Business keywords: Bio-fabrication, Regenerative medicine, Tissue engineering, Transplantation, Bio-printing, 4D bio-fabricated tissues, Organ transplantation, Medical technology, Healthcare innovation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $12.00M | 2 |
|
18 Jul 2022 |
| Debt Financing | $15.53M | - |
|
03 Nov 2018 |
Precise Bio Alternatives & Competitors
View All Alternatives
Do not risk your patients. Trust. VIVIAN takes care.
推动移植邻域的创新与发展，助理患者长期存活
Pioneering the future of organ transplantation with human-compatible organs grown from gene-edited p...
Qihan Biotechnology Co., Ltd.
FAQ About Precise Bio
Source: BounceWatch company record for Precise Bio, https://bouncewatch.com/company/precise-bio, updated 30 December 2024. When citing, please name BounceWatch and link this page.
